首页> 外文期刊>Oxidative Medicine and Cellular Longevity >Phosphocreatine Improves Cardiac Dysfunction by Normalizing Mitochondrial Respiratory Function through JAK2/STAT3 Signaling Pathway In Vivo and In Vitro
【24h】

Phosphocreatine Improves Cardiac Dysfunction by Normalizing Mitochondrial Respiratory Function through JAK2/STAT3 Signaling Pathway In Vivo and In Vitro

机译:通过在体内和体外将线粒体呼吸功能正常化线粒体呼吸功能来改善心脏功能障碍。在体内和体外,通过JAK2 / Stat3信号传导途径来改善心脏功能障碍

获取原文
       

摘要

Diabetic cardiomyopathy (DCM) is one of the common cardiovascular complications in patients with diabetes. Accumulating evidence has demonstrated that DCM is thoroughly related to mitochondrial energy impairment and increases the generation of reactive oxygen species (ROS). Therefore, an ongoing study is developing strategies to protect cardiac mitochondria from diabetic complications, especially from hyperglycemia. Phosphocreatine (PCr) plays a major metabolic role in cardiac muscular cells including intracellular concentration of ATP which affects the activity of the myocardium. We hypothesized that PCr might improve oxidative phosphorylation and electron transport capacity in mitochondria impaired by hyperglycemia in vivo and in vitro. Also, we aimed to evaluate the protective effect of PCr against DCM through the JAK2/STAT3 signaling pathway. The mitochondrial respiratory capacity from rats and H9C2 cells was measured by high-resolution respirometry (HRR). Expressions of proteins Bax, Bcl-2, caspase 3, caspase 9, cleaved caspase 3, and cleaved caspase 9, as well as JAK2/STAT3 signaling pathways, were determined by western blotting. ROS generation and mitochondrial membrane potential (MMP) were measured with fluorescent probes. Type 1 diabetes mellitus was induced in Wistar male rats by a single intraperitoneal injection of streptozotocin (STZ) (80?mg/kg body weight). Our results revealed that PCr possessed protective effects against DCM injury by improving the mitochondrial bioenergetics and by positively exerting protective effects against DCM in vivo and in vitro, not only improving diabetes symptom, resulting in changes of cardiac tissue using hematoxylin and eosin (H&E) stain, but also ameliorating biochemical changes. Moreover, PCr increased Bcl-2, caspase 3, and caspase 9 protein expressions and decreased Bax, cleaved caspase 3, and cleaved caspase 9 expressions as well as the JAK2/STAT3 signaling pathway. In conclusion, PCr improves mitochondrial functions and exerts an antiapoptotic effect in vivo and in vitro exposed to oxidative stress by hyperglycemia through the JAK2/STAT3 signaling pathway. Our findings suggest that PCr medication is a possible therapeutic strategy for cardioprotection.
机译:糖尿病心肌病(DCM)是糖尿病患者的常见心血管并发症之一。积累证据表明,DCM与线粒体能量损伤彻底相关,并增加了活性氧(ROS)的产生。因此,正在进行的研究正在制定保护心肌细胞免受糖尿病并发症的策略,特别是来自高血糖症。磷酸官(PCR)在心肌肌肉细胞中起主要的代谢作用,包括影响心肌的活性的ATP细胞内浓度。我们假设PCR可能改善由体内和体外血清血糖血症损害的线粒体中的氧化磷酸化和电子传输能力。此外,我们旨在通过JAK2 / Stat3信号通路评估PCR对DCM的保护作用。通过高分辨率呼​​吸测定法(HRR)测量来自大鼠和H9C2细胞的线粒体呼吸能力。通过蛋白质印迹测定蛋白质Bax,Bcl-2,胱天蛋白3,胱天蛋白酶9,切割的胱天蛋白3和切割的Caspase 9以及jak2 / stat3信号传导途径的表达。用荧光探针测量ROS产生和线粒体膜电位(MMP)。通过单一的腹腔注射链脲佐菌素(STZ)(80×Mg / kg体重),在Wistar阳性大鼠中诱导1型糖尿病。我们的研究结果表明,通过改善线粒体生物能源,通过改善线粒体生物能源,通过在体内和体外积极施加保护作用,不仅改善糖尿病症状,PCR对DCM损伤具有对DCM损伤的保护作用。 ,还改善了生化的变化。此外,PCR增加了Bcl-2,胱天蛋酶3和Caspase 9蛋白表达和减少的兔,切割的胱天蛋白3和切割的Caspase 9表达以及jak2 / stat3信号通路。总之,PCR改善了线粒体功能,并通过JAK2 / Stat3信号通路通过高血糖血症暴露于氧化应激的体内和体外施用抗曝光效应。我们的研究结果表明,PCR药物是心脏保护的可能治疗策略。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号